NCT00117767View on ClinicalTrials.gov

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

March 31, 2006

Conditions
Tinea Capitis
Interventions
DRUG

Terbinafine hydrochloride (HCl)

Terbinafine hydrochloride (HCl) pediatric formulation (minitablets)o.d. administration

DRUG

Griseofulvin

Griseofulvin pediatric suspension o.d. administration

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY